Alumni raised $1.45B in 2022 - Download Free Report Now

NKT Therapeutics

Therapeutics based on natural killer cells (NKT), a subset of immune cells, intended for the treatment of autoimmune and inflammatory diseases in add....

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of NKT Therapeutics plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About NKT Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With